<DOC>
	<DOCNO>NCT00437125</DOCNO>
	<brief_summary>This study aim assess tolerability duloxetine , 60mg daily , open label fashion , depress patient Parkinson 's disease 12 week treatment .</brief_summary>
	<brief_title>Study Tolerability Duloxetine Depressed Patients With Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Are outpatient , male female , 30 75 year age Meet diagnostic criterion major depression episode clinical diagnosis idiopathic Parkinson 's disease Have clinicianrated 17item Hamilton Depression Rating Scale ( HAMD17 ) total score great equal 15 , Beck Depression Inventory ( BDI ) total score great equal 13 Clinical Global Impression Severity ( CGIS ) score great equal 3 Visit 1 Visit 2 Have satisfactory cognitive function Have hold stable dosage antiparkinsonian medication least 4 week immediately prior Visit 1 Any current primary psychiatric diagnosis Major depressive episode , personality disorder could interfere compliance study protocol Atypical secondary parkinsonism due drug diseases feature Parkinson 's disease Motor condition expect change antiparkinsonian treatment course study Clinically significant laboratory abnormality serious , unstable medical illness Lack response current episode two adequate course antidepressant therapy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>